CHICAGO, Aug. 5, 2011 /PRNewswire/ -- Zacks.com releases
details on a group of stocks that are currently members of the
exclusive Zacks #5 Rank List – Stocks to Sell Now. These stocks are
currently rated as a Zacks Rank #5 (Strong Sell): Owen-
Illinois, Inc. (NYSE: OI) and
Lennox International Inc. (NYSE: LII). Further, Zacks
announced #4 Rankings (Sell) on two other widely held stocks:
Haemonetics Corporation (NYSE: HAE) and Hill-Rom
Holdings, Inc. (NYSE: HRC).
(Logo:
http://photos.prnewswire.com/prnh/20101027/ZIRLOGO)
To see the full Zacks #5 Rank List - Stocks to Sell Now visit:
http://at.zacks.com/?id=92
Since inception in 1988, the S&P 500 has outperformed the
Zacks #5 Rank List of Stocks to Sell Now by 80% annually (+2% vs.
+10%). While the rest of Wall Street continued to tout stocks
during the market declines of the last few years, Zacks told
investors which stocks to sell or avoid.
Here is a synopsis of why OI and LII have a Zacks Rank of #5
(Strong Sell) and should most likely be sold or avoided for the
next one to three months. Note that a #5 Strong Sell rating is
applied to 5% of all the stocks in the Zacks Rank universe:
Owen- Illinois, Inc.
(NYSE: OI) announced second-quarter profit of 59 cents per share on July
28 that missed analysts' expectations by 4.84%. The Zacks
Consensus Estimate for the current year slipped to $2.32 per share from $2.50 per share in the last 30 days as next
year's estimate dipped 24 cents per
share to $2.93 per share in that time
span.
Lennox International Inc. (NYSE: LII) posted a
second-quarter profit of 84 cents per
share on July 26, which came in
26 cents wider than the average
forecast. The Zacks Consensus Estimate for the full year fell to
$2.10 per share from $2.87 per share over the past month. For 2012,
analysts expect a profit of $2.99 per
share, compared to last month's projection for a profit of
$3.71 per share.
Here is a synopsis of why HAE and HRC have a Zacks Rank of 4
(Sell) and should also most likely be sold or avoided for the next
one to three months. Note that a #4 Sell rating is applied to 15%
of all the stocks ranked by Zacks;
Haemonetics Corporation (NYSE: HAE) first-quarter profit
of 65 cents per share, posted on
August 1, lagged analysts'
projections by 16.67%. Estimate for current year slid 18 cent per share to $3.39 per share over a month as next year's
estimate dipped 5 cents per share to
$3.91 per share in that time
span.
Hill-Rom Holdings, Inc. (NYSE: HRC) reported a
third-quarter profit of 47 cents per
share on July 27 that fell 12.96%
short of the Zacks Consensus Estimate. The full-year average
forecast is currently $2.26 per
share, compared with last month's projection of $2.33 per share. Next year's forecast dropped to
$2.53 per share from $2.63 per share in the same period.
Truly taking advantage of the Zacks Rank requires the
understanding of how it works. The free special report;
"Zacks Rank Guide: Harnessing the Power of Earnings Estimate
Revisions" is available to provide this insightful background.
Download a free copy now to prosper in the years to come at
http://at.zacks.com/?id=93
About the Zacks Rank
Since 1988, the Zacks Rank has proven that "Earnings estimate
revisions are the most powerful force impacting stock prices."
Since inception in 1988, #1 Rank Stocks have generated an average
annual return of +28%. During the 2000-2002 bear market, Zacks #1
Rank stocks gained +43.8%, while the S&P 500 tumbled -37.6%.
Also note that the Zacks Rank system has just as many Strong Sell
recommendations (Rank #5) as Strong Buy recommendations (Rank #1).
Since 1988, Zacks Rank #5 stocks have significantly underperformed
the S&P 500 (2.8% versus +9.7%). Thus, the Zacks Rank system
allows investors to truly manage portfolio trading effectively.
Visit http://www.zacks.com/performance for information about the
performance numbers displayed in this press release.
Zacks "Profit from the Pros" e-mail newsletter offers continuous
coverage of Zacks Rank Buy stocks and highlights those stocks
poised to outperform the market. Subscribe to this free newsletter
today by visiting http://at.zacks.com/?id=94
About Zacks
Zacks.com is a property of Zacks Investment Research, Inc.,
which was formed in 1978 by Len
Zacks. As a PhD from MIT Len knew he could find patterns in
stock market data that would lead to superior investment results.
Amongst his many accomplishments was the formation of his
proprietary stock picking system; the Zacks Rank, which continues
to outperform the market by nearly a 3 to 1 margin. The best way to
unlock the profitable stock recommendations and market insights of
Zacks Investment Research is through our free daily email
newsletter; Profit from the Pros. In short, it's your steady
flow of Profitable ideas GUARANTEED to be worth your time! Register
for your free subscription to Profit from the Pros at
http://at.zacks.com/?id=95
Follow us on Twitter: http://twitter.com/zacksresearch
Join us on Facebook:
http://www.facebook.com/ZacksInvestmentResearch
Zacks Investment Research is under common control with
affiliated entities (including a broker-dealer and an investment
adviser), which may engage in transactions involving the foregoing
securities for the clients of such affiliates.
Disclaimer: Past performance does not guarantee future
results. Investors should always research companies and
securities before making any investments. Nothing herein should be
construed as an offer or solicitation to buy or sell any
security.
Media Contact
Zacks Investment Research
800-767-3771 ext. 9339
support@zacks.com
http://www.zacks.com
SOURCE Zacks Investment Research, Inc.